CASPOVITAE

This brand name is authorized in Ecuador, Hong Kong SAR China.

Active ingredients

The drug CASPOVITAE contains one active pharmaceutical ingredient (API):

1	Caspofungin UNII VUW370O5QE - CASPOFUNGIN ACETATE
	Caspofungin acetate is a semi-synthetic lipopeptide (echinocandin) compound synthesised from a fermentation product of Glarea lozoyensis. Caspofungin acetate inhibits the synthesis of beta (1,3)-D-glucan, an essential component of the cell wall of many filamentous fungi and yeast. Beta (1,3)-D-glucan is not present in mammalian cells.
	Read more about Caspofungin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AX04	Caspofungin	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	7483-MEE-0922
HK	Department of Health Drug Office	66616, 66617